Identification
Personal identification
- Full name
- Inês Pereira Dias Marques
Citation names
- Marques, Inês P
- Marques, I
- Marque, IP
Author identifiers
- Ciência ID
- A816-8461-F97D
- ORCID iD
- 0000-0001-9170-6997
- Scopus Author Id
- 54789056900
Email addresses
- ipmarques@aibili.pt (Professional)
- inespdmarques@gmail.com (Personal)
Addresses
- AIBILI, Azinhaga de Santa Comba, Celas, 3000-548, Coimbra, Coimbra, Portugal (Professional)
Websites
- https://www.aibili.pt/units-centres/cec/ (Professional)
- https://www.aibili.pt/units-centres/corc/ (Professional)
Knowledge fields
- Medical and Health Sciences - Clinical Medicine - Ophthalmology
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Proficiency (C2) | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) |
French | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) |
Spanish; Castilian | Intermediate (B1) | Upper intermediate (B2) | Elementary (A2) | Intermediate (B1) | Intermediate (B1) |
Education
Degree | Classification | |
---|---|---|
2022/03/10 - 2022/03/10
Concluded
|
Grau de consultor da carreira médica (Outros)
Centro Hospitalar Tondela Viseu EPE, Portugal
|
Aprovado |
2014 - 2020/09/17
Concluded
|
Doutoramento em Ciências da Saúde (Doutoramento)
Universidade de Coimbra Faculdade de Medicina, Portugal
"PROGRESS – Progression of Diabetic Retinopathy. Identification of Signs and Surrogate outcomes." (THESIS/DISSERTATION)
|
|
2020/02/19 - 2020/02/19
Concluded
|
ICH-GCP in English (R2 version) Exam (Outros)
Major in Clinical Research
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
|
2013 - 2015
Concluded
|
European Retina Panel (ERP) II Program (Outros)
Major in Retina
Allergan AG, Switzerland
|
|
2013/04/26 - 2013/04/27
Concluded
|
European Board of Ophthalmology Diploma (EBOD) (Postgraduate Certificate)
Major in Ophthalmology
European Board of Ophthalmology, Ireland
|
178,5 valores (0- 200) |
2012/01/31 - 2012/11/08
Concluded
|
Principles and Practice of Clinical Research (Outros)
Harvard Medical School, United States
|
|
2012/10/20 - 2012/10/20
Concluded
|
Exame final da Especialidade de Oftalmologia (Título de especialista)
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
|
97/100 |
2008/04/01 - 2012/10/20
Concluded
|
Internato Complementar de Oftalmologia (Especialização pós-licenciatura)
Major in Oftalmologia
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
|
97 (0-100) |
2012/06/04 - 2012/06/04
Concluded
|
Data presentation and Manuscript Writing workshop (Outros)
Major in Clinical Research
Harvard Medical School, United States
|
|
2010/09/01 - 2010/11/30
Concluded
|
Fellowship (Outros)
Major in Medical Retina and Uveitis
Moorfields Eye Hospital NHS Foundation Trust, United Kingdom
|
|
2010/05/28 - 2010/06/30
Attended
|
Curso de formação profissional: SPSS Avançado (Outros)
Major in Estatística
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
|
|
2009/12/14 - 2010/01/11
Concluded
|
Curso Básico de SPSS em ambiente windows-Módulo I (Outros)
Major in Estatística
Central de estudos de Medicina Geral e Familiar, Portugal
|
|
2007 - 2008
Attended
|
Internato Complementar de Cardiologia Pediátrica (Especialização pós-licenciatura)
Major in Cardiologia Pediátrica
Centro Hospitalar de Lisboa Central EPE, Portugal
|
|
2007/10 - 2007/10
Concluded
|
Exame de acesso ao Internato Complementar de Especialidade (Outros)
Hospitais da Universidade de Coimbra, Portugal
|
86/100 |
2006 - 2006
Concluded
|
Internato Geral de Medicina (Especialização pós-licenciatura)
Centro Hospitalar de Lisboa Central EPE, Portugal
|
|
1999/09 - 2005/06/29
Concluded
|
Medicina (Licenciatura)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
16 (0-20) |
2003/09/15 - 2004/07/20
Concluded
|
Programa Socrates/ERASMUS (Outros)
Major in Medicina
Université Libre de Bruxelles, Belgium
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2008 - Current | Researcher (Research) | Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2015/09 - 2016/06 | Assistant (University Teacher) | Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal |
Hospital de Sousa Martins, Portugal | ||
2009 - 2011 | Assistant (University Teacher) | Universidade de Coimbra Faculdade de Medicina, Portugal |
Hospitais da Universidade de Coimbra, Portugal |
Other Careers
Category Host institution |
Employer | |
---|---|---|
2018 - 2019 | Assistente (Médica) | Centro Hospitalar do Baixo Vouga EPE, Portugal |
2013 - 2017 | Assistente (Médica) | Unidade Local de Saúde da Guarda EPE, Portugal |
2008 - 2012 | Interno (Médica) | Centro Hospitalar e Universitário de Coimbra EPE, Portugal |
2006 - 2008 | Interno (Médica) | Centro Hospitalar de Lisboa Central EPE, Portugal |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2020 - Current | Organic Unit Director | Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2015 - Current | Project Coordinator and Medical Grader | Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2023/09 - 2025/05 | QUASAR - Efficacy and Safety of High Dose Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion
EU-CT number: 2022-502174-16-00
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Bayer AG
Ongoing
|
2022/03 - 2025 | Retinal ischemia characterization in diabetes RICHARD
NCT05112445
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Boehringer Ingelheim AB
Ongoing
|
Contract
Designation | Funders | |
---|---|---|
2020/12 - Current | A Phase 2 randomized, placebo-controlled, double-masked proof-of-concept and dose-finding study to investigate the efficacy
and safety of runcaciguat (BAY 1101042) in patients with moderately severe to severe non-proliferative diabetic retinopathy
BAY1101042_ 20739
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Bayer AG
Ongoing
|
2020/10 - Current | RECOGNISED - Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients
at risk of dementia.
ECR-RET-2019-14
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Fundació Hospital Universitari Vall D’Hebron, VHIR
Ongoing
|
2019/12 - Current | RECOGNISED - Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients
at risk of dementia
ECR-RET-2019-14
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2018/07 - Current | CORDIS - Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive
Imaging methods, in a longitudinal, prospective and interventional clinical Study with 2 years of duration
Protocol CEC/194/18
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Associação para a Inovação e Desenvolvimento da FCT
Ongoing
|
2018/02 - Current | MACUSTAR / ECR-AMD-2017-13 - Development of novel clinical endpoints for interventional clinical trials with a regulatory
and patient access intention in patients with intermediate age-related macular degeneration (AMD
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
European Union
Ongoing
|
2023/04 - 2025/08 | MEERKAT - A phase III, multicenter, randomized, double-masked, sham-controlled study to investigate the efficacy, safety,
pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with uveitic macular edema
EU Trial Number: 2022-501793-19-00
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
F Hoffmann-La Roche AG Research and Development Division
Ongoing
|
2018/07/01 - 2022/06/30 | CORDIS
PTDC/MEC-OFT/30375/2017
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2018/10 - 2022 | CORDIS - Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive
Imaging methods, in a longitudinal, prospective and interventional clinical Study with 2 years of duration
CEC/194/18
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Associação para a Inovação e Desenvolvimento da FCT |
2012 - 2016 | LUMINOUS - RFB002A2406
NCT01318941
Researcher
|
Concluded
|
2012 - 2015 | EUROCONDOR / 4C-2011-02 - Neurodegeneration as an early event in the pathogenesis of DR: A trial to assess the efficacy of
neuroprotective drugs administered topically to prevent or arrest DR.
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
European Union
Concluded
|
Other
Designation | Funders | |
---|---|---|
2021/03 - Current | Characterization of Retinal disease progression in eyes with NPDR in diabetes Type 2 using non-invasive procedures CHART
NCT04636307
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Bayer Antwerpen NV
Ongoing
|
2020 - Current | KALAHARI - A study to evaluate THR-149 treatment for diabetic macular oedema
THR-149-002
IND: 137669
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Oxurion
Ongoing
|
2019/09 - Current | PANDA KHB-1801 A Multicenter, Double Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept
Intravitreal Injection in Subjects with Neovascular Age-Related Macular Degeneration
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2019/03 - Current | OPTIMUM LT / AC-058B303 - Multicenter, non-comparative extension to study AC-058B301, to investigate the long-term safety,
tolerability, and control of disease of ponesimod 20 mg in subjects with relapsing multiple sclerosis.
AC-058B303
ClinicalTrials.gov: NCT03232073
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Actelion Clinical Research Inc |
2016 - Current | A multi-site, open-label extension Trial of Oral RPC1063 in relapsing Multiple Sclerosis
Protocol RPC01-3001
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2016 - Current | OPTIMUM - Multicenter, randomised, double-blind, parallel-group, active-controlled, superiority study to compare the efficacy
and safety of ponesimod to teriflunomide in subjects with relapsing multiple sclerosis
Protocol AC-058301
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2015 - Current | IRISS - An open label, registry study of the safety of LUVIEN® 190 micrograms intravitreal implant in applicator
Protocol M-01-12-001
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2015 - Current | AZURE - An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability
of 2 mg aflibercept administered by intravitreal injections using two different treatment regimens to subjects with neovascular
age-related macular degeneration (nAMD)
Protocol BAY 86-5321 / 16598
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2015 - Current | EYEMARKER - Characterization of poential biomarkers of Eye Disease and Vision Loss
Protocol 4C-2015-08
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2018 - 2022 | Xplore / XBR1001 - Xplore: A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety
of Xlucane versus Lucentis® in Patients with Neovascular Age-Related Macular Degeneration.
ClinicalTrials.gov: NCT03805100
XBR1001
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Xbrane Biopharma |
2020/06 - 2021 | ReFineDR: Observational study of Routine ophthalmological examinations of patients included in the 2 Bayer sponsored phase
3 clinical trials FIDELIO and FIGARO to investigate the effect of Finerenone on delaying the progression of Diabetic Retinopathy
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2018 - 2021 | RHINE - A phase III, multicentre, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and
safety of RO6867461 in patients with diabetic macular edema
Protocol GR40398
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2017 - 2021 | PROGRESS – Progression of Diabetic Retinopathy. Identification of Signs and Surrogate outcomes
Protocol CEC/007/2016
Principal investigator
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Ongoing
|
2020/06 - 2020/12/05 | Alimera_Protocol 01-20-005 - The New Day Study - A Randomized, Masked, Controlled Study of Intravitreal ILUVIEN ® Implant
as Baseline Therapy in Patients with Early Diabetic Macular Edema (DME)
Protocol 01-20-005
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Alimera Sciences Inc
Ongoing
|
2018 - 2020 | KESTREL - A two-year, three-arm, randomized, double-masked, multicentre, phase III study assessing the efficacy and safety
of brolucizumab versus aflibercept in adult patients with visual impairment due to diabetic macular edema
Protocol CRTH258B2301
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
|
2017/12 - 2019/11 | THR-317-002 - A study to evaluate the efficacy and safety of intravitreal THR-317 when administered alone or in combination
with Lucentis®, in DME patients with a poor or no response to anti-VEGF treatment.
ClinicalTrials.gov: NCT03410693
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Oxurion
Concluded
|
2016 - 2019 | VIOLET/BAY 86-5321 / 17613 - An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy,
safety, and tolerability of three different treatment regimens of 2 mg aflibercept administered by intravitreal injections
to subjects with diabetic macular edema(DME)
Protocol BAY 86-5321 / 17613
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2017/12 - 2018/10 | THR-317-001 - Additional OCT Analysis
ClinicalTrials.gov: NCT03071068
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
ThromboGenics NV
Concluded
|
2016/08 - 2018/10 | THR-317-001 - A Phase 2, single-masked, multicentre study to evaluate the safety and efficacy of 2 dose levels of THR317 for
the treatment of diabetic macular oedema (DME).
ClinicalTrials.gov: NCT03071068
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
ThromboGenics NV
Concluded
|
2018 - 2018 | A randomized , open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877) compared
to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior
platinum-containing chemotherapy
Protocol BAY 1163877/17403
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Cancelled
|
2015 - 2018 | ATLANTIC - A randomized, double-masked, sham-controlled phase 4 study of the efficacy, safety, and tolerability of intravitreal
aflibercept monotherapy compared to aflibercept with adjunctive photodynamic therapy in patients with polypoidal choroidal
vasculopathy
Protocol ECR-AMD-2015-09
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2018 | HARRIER - A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6
mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration
Protocol RTH258-C002
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015/04 - 2017/11 | AQUA/BAY 86-5321 /17850 - Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with
diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept according to EU label for the
first year of treatment.
ClinicalTrials.gov: NCT02581995
BAY 86-5321 /17850
Technical development
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Bayer AG
Concluded
|
2017 - 2017 | OMASPECT - A multi-center, open label extension study to evaluate the long-term safety and tolerability of Lampalizumab in
patients with Geographic atrophy secondary to Age-related Macular Degeneration
Protocol GX30191
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2016 - 2017 | AMDIncidencePT - Five-year incidence of Age-related Macular Degeneration in the central region of Portugal
Protocol 4C-2016-09
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2016 - 2017 | A randomized, double-masked, placebo-controlled exploratory study to evaluate pharmacodynamics, safety and tolerability of
orally administered BI 1026706 for 12 weeks in patients with mild visual impairment due to center-involved diabetic macular
edema (DME)
Protocol BI 1320.22
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Boehringer Ingelheim Chemicals Inc
Concluded
|
2015 - 2017 | SPECTRI - A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of
lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration
Protocol GX29185
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2017 | SUNBEAM - A phase III, multicenter, randomized, double-blind, double-dummy, active controlled, parallel group study to evaluate
the efficacy and safety of RPC1063 administered orally to relapsing multiple sclerosis patients
Protocol RPC01-301
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2017 | THEA-UNAV1/14 - An Interventional, multicentre, randomized study of nutritional supplements in unilateral wet AMD
Protocol THEA-UNAV1/14
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2017 | Genotypic and Phenotypic characterization of retinal angiomatous proliferation (RAP) lesions
Protocol CEC 006/2015
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2017 | EPOCH - A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with
Mild to Moderate Alzheimer’s Disease
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2017 | SALT - Study to compare efficacy of 0.5 mg ranibizumab PRN versus 2 mg aflibercept bimonthly intravitreal injections on retinal
thickness stability till month 6 of treatment and explore functional outcomes up to month 12 in patients with neovascular
(wet) age-related macular degeneration (AMD)
Protocol CRFB002ADE23
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2017 | FOVISTA - Trial to establish safety and efficacy of intravitreous FOVISTA TM (Anti PDGF-B Pegylated Aptamer) administered
in combination with either Avastin® or Eylea® compared to Avastin® or Eylea® Monotherapy in subjects with subfoveal neovascular
Age-Related Macular Degeneration
Protocol OPH1004
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2016 | IN0654 - Metabolomics, Genetics and Environment – a novel integrative approach to Age-Related Macular Degeneration
IN0654
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2015 - 2016 | OCTA - Clinical evaluation of noninvasive OCT Angiography using a Zeiss OCT Prototype to compare to fluorescein angiography
Protocol 4C-2015-07
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2016 | PROTEUS - Prospective, randomized, multicentre, open label, phase II / III study to assess efficacy and safety of ranibizumab
0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versusPRP in monotherapy in the treatment of subjects
with high risk proliferative diabetic retinopathy
Protocol ECR-RET-2013-05
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2016 | ARTES - A Collaborative Retrospective Trial on the Efficacy and Safety of intravitreal dexamethasone implant (Ozurdex) in
patients with Diabetic Macular Edema (DME). The European DME Registy Study
Protocol ECR-RET-2014-07
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2013 - 2016 | CHARTRES - Characterization of Eyes with Diabetic Macular Edema that show different Treatment Response to Intravitreal anti-VEGF
Protocol 4C-2013-05
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2011 - 2016 | A follow-up study evaluating the long-term safety of lacosamide (200 to 600mg/day) in comparison with carbamazepine (400 to
1200mg/day), used as monotherapy in subjects with partial-onset or generalized tonic-clonic seizures =16 years of age coming
from the SP0993 study
Protocol SP0994
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2015 | JETREA - Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic
Vitreomacular Adhesion (VMT/sVMA)
Protocol M-13-056
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2012 - 2015 | C-Tracer - Biomarkers of Diabetic Retinopathy Progression
Protocol 4C-2012-02
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2011 - 2015 | BRIGHTER - A phase IIIb study assessing efficacy and safety of PRN dosing regimen with 0,5mg ranibizumab monotheraphy or with
adjunctive laser photocoagulation in comparison to laser photocoagulation in patients with visual impairment due to macular
edema secondary to branch vein occlusion (BRVO)
Protocol CRFB002E2402
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2014 - 2014 | SPORT - Intraocular pressure and tolerability Study of Preservative Free Bimatoprost 0,03% Unit Dose (BUDPF) or preservative
free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost) in patients with Ocular hypertension or glaucoma
Protocol ECR-GLC-2013-06
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2012 - 2014 | CRYSTAL - A phase IIIb study assessing efficacy and safety of PRN dosing regimen with 0.5-mg ranibizumab monotherapy in patients
with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO)
Protocol CRFB002E2401
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Concluded
|
2013 - 2013 | BENEFIT - Long-term, follow-up study (16401) of the BENEFIT (304747),BENEFIT Follow-up (305207) Studies and BENEFIT Extension
(311129) Study to further evaluate theprogress of patients with first demyelinating event suggestive of multiple sclerosis
Researcher
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
Bayer AG
Concluded
|
Outputs
Publications
Book chapter |
|
Conference poster |
|
Journal article |
|
Newsletter article |
|
Newspaper article |
|
Thesis / Dissertation |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/02/09 | Biomarcadores Retinianos no OCT | Colóquios de Oftalmologia 2024
Hospital de Santa Maria (Lisboa, Portugal)
|
2023/06/02 | Multimodal Imaging for detection of DR lesions | EASDEC meeting 2024
EASDEC and AIBILI (Coimbra)
|
2023/06 | Swept-source OCTA discriminates severity staging of NPDR: The CHART Study | EASDEC Meeting 2023
EASDEC and AIBILI (Coimbra, Portugal)
|
2023/03/24 | Biomarkers in Diabetic Macular Edema | 7ª Reunião GER
Grupo de Estudos de Retina. Portugal
|
2022/11/10 | A relação entre a PHDA e a Retina | Congresso Nacional de PHDA 2022
SPDA (Porto, Portugal)
|
2021/10/28 | Ganglion Cell-Inner Plexiform layer alteration in the initial stages of diabetic retinopathy in type 2 diabetic patients: a 5-year longitudinal study | EASDec Congress 2021
EASDEC (Odense, Denmark)
|
2021/07/17 | Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study | Posterior Segment Day of Pan-American Research Day
Pan-American Association of Ophthalmology (Virtual)
|
2020/11/05 | Different Retinopathy Phenotypes in DR type 2 show different five -year risks for development of DME and PDR | EASDec Congress 2020
(Barcelona, Spain)
|
2019/12/07 | Estudo CORDIS - Um ensaio longitudinal perspetivo e intervencional numa população de doentes diabéticos tipo 2 com retinopatia ligeira a moderada | 62º Congresso Português de Oftalmologia
(Vilamoura, Portugal)
|
2019/09/05 | Five-year progression of diabetic retinopathy (PROGRESS Study) - DR Phenotypes as predictors of 5-year progression | 19th EURETINA Congress
(Paris, France)
|
2019/05/16 | Multimodal imaging of the initial stages of diabetic retinopathy: different disease pathways in different patients | EASDec Congress 2019
(Amsterdam , Netherlands)
|
2018/10 | Palestrante em Sessão Clínica: DMI e EMD - update | Sessão Clínica: DMI e EMD
Bayer (Aveiro, Portugal)
|
2018/09/20 | Characterization of the initial stages of diabetic retinal disease using OCT and OCTA | 18th EURETINA Congress
EURETINA - European Society of Retina Specialists (Viena, Austria)
|
2018/09 | Palestrante na sessão: Eyecare retina - restabelece o equilíbrio na progressão da RD | Sessão: Eyecare retina
Davi (Coimbra, Portugal)
|
2018/07 | Palestrante em Sessão Clínica: VEGF - Clinical cases | Sessão Clínica: VEGF
Novartis (Aveiro, Portugal)
|
2018/07 | Palestrante no curso de formação interna da AIBILI: Doenças oftálmicas e Técnicas de Diagnóstico | Curso de formação interna da AIBILI: Doenças oftálmicas e Técnicas de Diagnóstico
AIBILI (Coimbra, Portugal)
|
2018/05 | Characterization of the initial stages of diabetic retinopathy using OCT and OCTA | EASDEC 2018
EASDEC - European Association for the Study of Diabetes Eye Complications (Belfast, United Kingdom)
|
2016/12/08 | Uso de anti-VEGF no tratamento das oclusões venosas em Portugal - resultados da prática clínica | 59º Congresso Português de Oftalmologia
(Coimbra, Portugal)
|
2016/12/08 | Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography | 59º Congresso Português de Oftalmologia
(Coimbra, Portugal)
|
2016/12 | Uso de ANTI-VEGF no tratamento das oclusões venosas em Portugal - Resultados da prática clínica | 59º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
|
2016/09/08 | Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography | 16th EURETINA Congress
(Copenhaga, Denmark)
|
2016/06/04 | Palestrante em VIOLET STUDY Investigator Meeting - Central Reading Center Procedures | VIOLET STUDY Investigator Meeting
(viena, Austria)
|
2016/06 | Methods for Quantification of Retinal Microvascular Density in Cirrus AngioPlex OCT Angiography (OCTA) Images | EASDEC 2016
EASDEC - European Association for the Study of Diabetes Eye Complications (Manchester, United Kingdom)
|
2015/02/07 | Novas Perspectivas em tomografia de coerência óptica do segmento posterior - Apresentação de casos clínicos | Sessões Clínicas do Hospital da Luz
(Lisboa, Portugal)
|
2014/10 | Neuroprotecção em Glaucoma |
Davi (Coimbra, Portugal)
|
2013/01 | Palestrante no Curso de Formação Básica em Oftalmologia: DMI e Angiogénese- Anatomia e Fisiologia Ocular. Ensaios Clínicos com anti-VEGF | Curso de Formação Básica em Oftalmologia
AIBILI (Coimbra, Portugal)
|
2011/12 | Moxifloxacina intracamerular (0,5% vs 0,25%) vs Cefuroxima intracamerular profiláctica na cirurgia de catarata- Estudo comparativo | 54º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Vilamoura, Portugal)
|
2011/12 | Terapia combinada com ranibizumab e terapia fotodinâmica no tratamento da Vasculopatia Polipoidal Idiopática- resultados visuais e anatómicos | 54º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Vilamoura, Portugal)
|
2011/09 | Prophylactic intracameral moxifloxacin (0.5% vs 0.25%) and cefuroxime in modern cataract surgery | XXIX Congress of the ESCRS
ESCRS - European Society of Cataract and Refractive Surgeons (Viena)
|
2011/06 | Intravitreal injection of Ranibizumab for AMD: 3 years experience. What determines the outcome? | Joint Congresso of SOE AAO
SOE - Sociedade Espanhola de Oftalmologia (SOE) (Genebra, Switzerland)
|
2011/04 | Autosomal Dominant Optic Atrophy- Clinical and molecular characterization of ten Portuguese families | XVIII Curso Panamericano de la Asociación Panamericana de Oftalmología
PAAO - Asociación Panamericana de Oftalmología (Estoril, Portugal)
|
2010/09 | Intravitreal injection of Ranibizumab for AMD: 3 years experience. What determines the outcome? | 10th EURETINA 2010
EURETINA - European Society of Retina Specialists (Paris, France)
|
2009/12 | Correcção cirúrgica de malposição palpebral senil- Resultados de uma técnica | 52º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Vilamoura, Portugal)
|
2009/12 | O Ranibizumab no tratamento das membranas ocultas, minimamente clássicas e predominantemente clássicas da DMRI | 52º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Vilamoura, Portugal)
|
2009/07 | Tumor da órbita e seios perinasais | Reunião Conjunta dos Grupos Portugueses de Inflamação Ocular, Oftalmologia Pediátrica e Estrabismo e Patologia, Oncologia
e Genética Ocular
(Funchal, Portugal)
|
2009/07 | Pseudo-chalázio palpebral | Reunião Conjunta dos Grupos Portugueses de Inflamação Ocular, Oftalmologia Pediátrica e Estrabismo e Patologia, Oncologia
e Genética Ocular
(Funchal, Portugal)
|
2009/07 | Retinite em HIV | Reunião Conjunta dos Grupos Portugueses de Inflamação Ocular, Oftalmologia Pediátrica e Estrabismo e Patologia, Oncologia
e Genética Ocular
(Funchal, Portugal)
|
2008/12 | Microscopia Confocal no diagnóstico das infecções corneanas | 51º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia (Porto, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2018 - 2019 | Characterization of Retinal Disease Progression in a 5-Year Longitudinal Study of Eyes with nonproliferative Retinopathy in
Diabetes Type 2
Co-supervisor
|
Mestrado integrado em Medicina (Master)
Universidade de Coimbra, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2023/06/01 - 2023/06/03 | EASDEC 2023 conference organization, since the logistics to the scientific program. (2023/06/01 - 2023/06/03)
Congress (President of the Organising Committee)
|
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2023/08/27 - 2023/08/28 | Participação na reunião do Grupo Português de Retina e Vítreo
Congress
|
Reunião do Grupo Português de Retina e Vítreo |
2023/04/21 - 2023/04/27 | Poster presenter - Characterization of two-year progression of capillary closure in nonproliferative diabetic retinopathy
Congress
|
ARVO Annual Meeting 2023
Arvo Foundation for Eye Research, United States
|
2021/07/17 - 2021/07/17 | Posterior Segment Day of Pan-American Research Day - Apresentação de comunicação oral
Congress
|
Posterior Segment Day of Pan-American Research Day
Pan-American Association of Ophthalmology, United States
|
2021/05/01 - 2021/05/07 | ARVO Annual Meeting 2021-Apresentação de poster
Congress
|
ARVO Annual Meeting 2021
Arvo Foundation for Eye Research, United States
|
2020/12/10 - 2020/12/12 | 63° Congresso Português de Oftalmologia
Congress
|
63° Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia, Portugal
|
2020/11/05 - 2020/11/07 | EASDec 2020 30th Annual Virtual Meeting
Congress
|
EASDec 2020 30th Annual Virtual Meeting
EASDec-European Association for the Study of Diabetes Eye Complications Study Group, United Kingdom
|
2020/10/02 - 2020/10/04 | EURETINA 2020 Virtual
Congress
|
20th EURETINA Congress
EURETINA - European Society of Retina Specialists, Ireland
|
2020/01/18 - 2020/01/19 | Reunião do GER
Meeting
|
Reunião do GER
GER - Grupo de Estudos de Retina de Portugal, Portugal
|
2019/12/05 - 2019/12/07 | 62º Congresso da Sociedade Portuguesa de oftalmologia
Congress
|
62º Congresso da Sociedade Portuguesa de oftalmologia
Sociedade Portuguesa de Oftalmologia, Portugal
|
2019/09/05 - 2019/09/08 | 19th EURETINA 2019. Paris, France
Congress
|
EURETINA 2019
EURETINA - European Society of Retina Specialists, Ireland
|
2018/12/05 - 2018/12/08 | 61º Congresso Português de Oftalmologia. Vilamoura, Portugal
Congress
|
61º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia, Portugal
|
2018/11/09 - 2018/11/10 | II Reunião Conjunta do Grupo Português de Retina e Vítreo e da Sociedade Espanhola de Retina e Vítreo
Congress
|
II Reunião Conjunta do Grupo Português de Retina e Vítreo e da Sociedade Espanhola de Retina e Vítreo
Sociedade Portuguesa de Oftalmologia, Portugal
|
2018/09/20 - 2018/09/23 | 18th EURETINA Congress - Vienna, Austria
Congress
|
18th EURETINA 2018
EURETINA - European Society of Retina Specialists, Ireland
|
2018/05/24 - 2018/05/26 | 28th EASDec Annual Meeting - Belfast, Northern Ireland
Congress
|
EASDec 2018
EASDec-European Association for the Study of Diabetes Eye Complications Study Group, United Kingdom
|
2017/06/22 - 2017/06/22 | 4th Annual Coimbra Champalimaud Symposium
Seminar
|
4th Annual Coimbra Champalimaud Symposium
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
2017/03/25 - 2017/03/25 | Reunião Científica Internacional do Grupo Estudos da Retina de Portugal. Lisboa, Portugal
Congress
|
Reunião Científica Internacional do Grupo Estudos da Retina de Portugal
Sociedade Portuguesa de Oftalmologia, Portugal
|
2016/12/08 - 2016/12/10 | 59º Congresso Português de Oftalmologia. Coimbra, Portugal
Congress
|
59º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia, Portugal
|
2016/09/08 - 2016/09/11 | 16th EURETINA Congress - Copenhagen, Denmark
Congress
|
16th Congress - European Society of Retina Specialists
EURETINA - European Society of Retina Specialists, Ireland
|
2016/06/22 - 2016/06/23 | EUROPEAN CONSORTIUM FOR THE EARLY TREATMENT OF DIABETIC RETINOPATHY - 6th General Assembly. Manchester, United Kingdom
Round table
|
6th General Assembly - EUROCONDOR |
2016/06/17 - 2016/06/18 | XXVI Jornadas de Oftalmologia. Coimbra, Portugal
Congress
|
XXVI Jornadas de Oftalmologia
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
|
2016/05/23 - 2016/05/25 | 26th EASDec Annual Meeting - Manchester, United Kingdom
Congress
|
EASDec 2016
EASDec-European Association for the Study of Diabetes Eye Complications Study Group, United Kingdom
|
2016/03/31 - 2016/04/02 | 7th World Congress on Controversies in Ophthalmology. Warsaw, Poland
Congress
|
COPHy - World Congress on Controversies in Ophthalmology |
2016/03/11 - 2016/03/12 | Reunião do Grupo Português de Glaucoma e do Grupo Português de Inflamação Ocular. Viseu, Portugal
Congress
|
Reunião do Grupo Português de Glaucoma e do Grupo Português de Inflamação Ocular
Sociedade Portuguesa de Oftalmologia, Portugal
|
2015/12/03 - 2015/12/05 | 58º Congresso Português de Oftalmologia. Vilamoura, Portugal
Congress
|
58º Congresso Português de Oftalmologia
Sociedade Portuguesa de Oftalmologia, Portugal
|
2015/11/05 - 2015/11/08 | European Retina Panel Programme. London, United Kingdom
Congress
|
European Retina Panel Programme.
EURETINA - European Society of Retina Specialists, Ireland
|
2015/05/03 - 2015/05/05 | ARVO Annual Meeting 2015. Denver, EUA
Congress
|
ARVO Annual Meeting 2015
The Association for Research in Vision and Ophthalmology Inc, United States
|
2014/05/04 - 2014/05/08 | ARVO Annual Meeting 2014. Orlando, EUA
Congress
|
ARVO Annual Meeting 2014
The Association for Research in Vision and Ophthalmology Inc, United States
|
2013/06/28 - 2013/06/29 | International Symposium of Ophthalmology. Coimbra, Portugal
Symposium
|
International Symposium of Ophthalmology
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
|
2013/06/27 - 2013/06/27 | 3rd Annual Coimbra Champalimaud Symposium with the institutions recognized as C-TRACER by the Champalimaud Foundation: LV
Prasad Eye Institute in India, AIBILI in Coimbra and the Paulista Institute of Studies and Research in Ophthalmology from
S. Paulo, Brazil.
Symposium
|
3rd Annual Coimbra Champalimaud Symposium
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
2013/05/05 - 2013/05/09 | ARVO Annual Meeting 2013. Seattle, EUA
Congress
|
ARVO Annual Meeting 2013
The Association for Research in Vision and Ophthalmology Inc, United States
|
2010/09/04 - 2010/09/08 | Congress of European Society of Cataract and Refractive Surgeons. Paris, France
Congress
|
XXVIII Congress of European Society of Cataract and Refractive Surgeons.
European Society of Cataract and Refractive Surgeons, Ireland
|
2010/09/02 - 2010/09/05 | 10th Congress of the European Society of Retina Specialists. Paris, France
Congress
|
10th Congress of the European Society of Retina Specialists.
EURETINA - European Society of Retina Specialists, Ireland
|
2008/09/13 - 2008/09/17 | Congress of the European Society of Cataract and Refractive Surgeons. Berlin, Germany
Congress
|
XXVI Congress of the European Society of Cataract and Refractive Surgeons
European Society of Cataract and Refractive Surgeons, Ireland
|
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2023/04/14 - Current | The Clinical Trial Process | (Curso de doutoramento (conclusão de unidades curriculares)) | Faculdade Medicina UNiversidade Coimbra, Portugal |
2023 - Current | Curso de Formação Avançada em Oftalmologia da SPO - Maculopatias Agudas | Sociedade Portuguesa de Oftalmologia, Portugal | |
2022/01 - Current | MEDICAL RETINA COURSE - Acute Maculopaties | GER - Grupo de Estudos de Retina de Portugal, Portugal | |
2023/03/13 - 2023/03/17 | Multiple disease pathways in diabetic retinopathy | (Mestrado integrado) | Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal |
2022/02/22 - 2022/02/22 | Abordagem prática em Medicina Geral e Familiar de aspetos relacionados com Oftalmologia: Consideração gerais; Abordagem diagnóstica e terapêutica de: olho vermelho, perda súbita de visão, diplopia, traumatismo ocular; Rastreio oftalmológico de grupos vulneráves: crianças, idosos, diabéticos | Formação Medicina Geral e Familiar, Portugal | |
2018/05 - 2018/06 | Novas perspectivas em Angio-OCT | Novas perspectivas em Angio-OCT (3 sessões; 9h/cada) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
2009 - 2011 | Assistente da cadeira de Oftalmologia | Medicina (Licenciatura) | Universidade de Coimbra Faculdade de Medicina, Portugal |
Distinctions
Award
2016 | Melhor Poster - Reunião GER 2016
GER - Grupo de Estudos de Retina de Portugal, Portugal
|
2011 | 2do. Premio al mejor trabajo - XVIII Curso Panamericano de la Asociación Panamericana de Oftalmología (PAAO) 2011
Pan-American Association of Ophthalmology, United States
|
2009 | Prémio SPO/Novartis - Melhor Apresentação na Área da Retina do Congresso SPO 2009
Sociedade Portuguesa de Oftalmologia, Portugal
|
2008 | Prémio Plácido 2008 – Melhor Trabalho no Congresso SPO 2008
Sociedade Portuguesa de Oftalmologia, Portugal
|